Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer | Patent Number 11091439

US 11091439 B2
Application Number17070514
Publication NumberUS 20210024467 A1
Pendency10 months, 7 days
Filled DateOct 14, 2020
Priority DateJan 16, 2009
Publication DateJan 28, 2021
Expiration DateJan 15, 2029
Inventor/ApplicantsPeter Lamb
Adrian St. Clair Brown
William P. Gallagher
ExaminesROZOF, TIMOTHY R
Art Unit1625
Technology Center1600
Assignments
Pharmorphix
Current
Exelixis Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.